First Time Loading...

Progyny Inc
NASDAQ:PGNY

Watchlist Manager
Progyny Inc Logo
Progyny Inc
NASDAQ:PGNY
Watchlist
Price: 33.06 USD 2.04% Market Closed
Updated: May 8, 2024

Intrinsic Value

Progyny, Inc. is a fertility benefits management company. [ Read More ]

The intrinsic value of one PGNY stock under the Base Case scenario is 42.95 USD. Compared to the current market price of 33.06 USD, Progyny Inc is Undervalued by 23%.

Key Points:
PGNY Intrinsic Value
Base Case
42.95 USD
Undervaluation 23%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Progyny Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling PGNY stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Progyny Inc

Provide an overview of the primary business activities
of Progyny Inc.

What unique competitive advantages
does Progyny Inc hold over its rivals?

What risks and challenges
does Progyny Inc face in the near future?

Has there been any significant insider trading activity
in Progyny Inc recently?

Summarize the latest earnings call
of Progyny Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Progyny Inc.

Provide P/S
for Progyny Inc.

Provide P/E
for Progyny Inc.

Provide P/OCF
for Progyny Inc.

Provide P/FCFE
for Progyny Inc.

Provide P/B
for Progyny Inc.

Provide EV/S
for Progyny Inc.

Provide EV/GP
for Progyny Inc.

Provide EV/EBITDA
for Progyny Inc.

Provide EV/EBIT
for Progyny Inc.

Provide EV/OCF
for Progyny Inc.

Provide EV/FCFF
for Progyny Inc.

Provide EV/IC
for Progyny Inc.

Show me price targets
for Progyny Inc made by professional analysts.

What are the Revenue projections
for Progyny Inc?

How accurate were the past Revenue estimates
for Progyny Inc?

What are the Net Income projections
for Progyny Inc?

How accurate were the past Net Income estimates
for Progyny Inc?

What are the EPS projections
for Progyny Inc?

How accurate were the past EPS estimates
for Progyny Inc?

What are the EBIT projections
for Progyny Inc?

How accurate were the past EBIT estimates
for Progyny Inc?

Compare the revenue forecasts
for Progyny Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Progyny Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Progyny Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Progyny Inc compared to its peers.

Compare the P/E ratios
of Progyny Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Progyny Inc with its peers.

Analyze the financial leverage
of Progyny Inc compared to its main competitors.

Show all profitability ratios
for Progyny Inc.

Provide ROE
for Progyny Inc.

Provide ROA
for Progyny Inc.

Provide ROIC
for Progyny Inc.

Provide ROCE
for Progyny Inc.

Provide Gross Margin
for Progyny Inc.

Provide Operating Margin
for Progyny Inc.

Provide Net Margin
for Progyny Inc.

Provide FCF Margin
for Progyny Inc.

Show all solvency ratios
for Progyny Inc.

Provide D/E Ratio
for Progyny Inc.

Provide D/A Ratio
for Progyny Inc.

Provide Interest Coverage Ratio
for Progyny Inc.

Provide Altman Z-Score Ratio
for Progyny Inc.

Provide Quick Ratio
for Progyny Inc.

Provide Current Ratio
for Progyny Inc.

Provide Cash Ratio
for Progyny Inc.

What is the historical Revenue growth
over the last 5 years for Progyny Inc?

What is the historical Net Income growth
over the last 5 years for Progyny Inc?

What is the current Free Cash Flow
of Progyny Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Progyny Inc.

Financials

Balance Sheet Decomposition
Progyny Inc

Current Assets 640.4m
Cash & Short-Term Investments 371.1m
Receivables 241.9m
Other Current Assets 27.5m
Non-Current Assets 116.2m
PP&E 27.8m
Intangibles 11.9m
Other Non-Current Assets 76.5m
Current Liabilities 186m
Accounts Payable 125.4m
Accrued Liabilities 60.5m
Non-Current Liabilities 17.2m
Other Non-Current Liabilities 17.2m
Efficiency

Earnings Waterfall
Progyny Inc

Revenue
1.1B USD
Cost of Revenue
-849.8m USD
Gross Profit
238.8m USD
Operating Expenses
-176.6m USD
Operating Income
62.2m USD
Other Expenses
-147k USD
Net Income
62m USD

Free Cash Flow Analysis
Progyny Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

PGNY Profitability Score
Profitability Due Diligence

Progyny Inc's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Exceptional 3-Years Revenue Growth
Positive 3-Year Average ROE
Positive Free Cash Flow
62/100
Profitability
Score

Progyny Inc's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

PGNY Solvency Score
Solvency Due Diligence

Progyny Inc's solvency score is 79/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
79/100
Solvency
Score

Progyny Inc's solvency score is 79/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PGNY Price Targets Summary
Progyny Inc

Wall Street analysts forecast PGNY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PGNY is 47.6 USD with a low forecast of 43.43 USD and a high forecast of 52.5 USD.

Lowest
Price Target
43.43 USD
31% Upside
Average
Price Target
47.6 USD
44% Upside
Highest
Price Target
52.5 USD
59% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

PGNY Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

PGNY Price
Progyny Inc

1M 1M
-8%
6M 6M
+12%
1Y 1Y
-5%
3Y 3Y
-35%
5Y 5Y
+107%
10Y 10Y
+107%
Annual Price Range
33.06
52w Low
29.51
52w High
42.9
Price Metrics
Average Annual Return 26.86%
Standard Deviation of Annual Returns 49.54%
Max Drawdown -61%
Shares Statistics
Market Capitalization 3.2B USD
Shares Outstanding 96 110 304
Percentage of Shares Shorted 8.45%

PGNY Return Decomposition
Main factors of price return

What is price return decomposition?

PGNY News

Other Videos

Company Profile

Progyny Inc Logo
Progyny Inc

Country

United States of America

Industry

Health Care

Market Cap

3.2B USD

Dividend Yield

0%

Description

Progyny, Inc. is a fertility benefits management company. The company is headquartered in New York City, New York and currently employs 311 full-time employees. The company went IPO on 2019-10-25. The firm specializes in fertility and family building benefits solutions in the United States. The firm provides its benefit through its Smart Cycle approach. The Smart Cycle includes medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition, to its fertility benefits solution, it offers an integrated pharmacy benefits solution, Progyny Rx, which is added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. As part of this solution, the Company provide care management services, which include its formulary plan design, simplified authorization, assistance with prescription fulfillment and timely delivery of the medications by its network of specialty pharmacies, as well as medication administration training, pharmacy support services and patient care advocates.

Contact

NEW YORK
New York City
1359 Broadway, 2Nd Floor
+12128883124.0
https://www.progyny.com/

IPO

2019-10-25

Employees

311

Officers

Executive Chairman
Mr. David J. Schlanger
CEO & Director
Mr. Peter Anevski
President
Mr. Michael Sturmer
Chief Financial Officer
Mr. Mark S. Livingston
General Counsel & Secretary
Ms. Allison Swartz
Chief Technology Officer
Mr. Steven Leist
Show More
Vice President of Investor Relations
Mr. James Hart
Chief Marketing Officer
Ms. Risa Fisher
Chief Human Resources Officer
Ms. Cassandra Pratt
Chief Business Development Officer
Ms. Julie Stadlbauer
Show Less

See Also

Discover More
What is the Intrinsic Value of one PGNY stock?

The intrinsic value of one PGNY stock under the Base Case scenario is 42.95 USD.

Is PGNY stock undervalued or overvalued?

Compared to the current market price of 33.06 USD, Progyny Inc is Undervalued by 23%.